WallStreetZenWallStreetZen

NASDAQ: CRVS
Corvus Pharmaceuticals Inc Stock Ownership - Who owns Corvus Pharmaceuticals?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Corvus Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Orbimed Advisors LLCDirector2025-06-271,397,684$3.50
$4.89MBuy
Orbimed Advisors LLCDirector2025-06-271,176,332$4.16
$4.89MSell
Peter A. ThompsonDirector2025-06-271,397,684$3.50
$4.89MBuy
Peter A. ThompsonDirector2025-06-271,176,332$4.16
$4.89MSell
William Benton JonesSVP Pharmaceutical Development2025-06-0419,357$3.50
$67.75kBuy
Richard A. Md MillerPresident and CEO2025-05-07559,073$3.50
$1.96MBuy

1 of 1

CRVS insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CRVS insiders and whales buy or sell their stock.

CRVS Shareholders

What type of owners hold Corvus Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Orbimed Advisors LLC9.59%7,165,006$56.03MInsider
Peter A. Thompson9.59%7,165,006$56.03MInsider
Orbimed Advisors LLC9.59%7,165,006$56.03MInstitution
Point72 Asset Management LP9.43%7,042,373$55.07MInstitution
Ecor1 Capital LLC6.91%5,162,154$40.37MInsider
Blackrock Inc5.68%4,238,410$33.14MInstitution
Adams Street Partners LLC4.56%3,402,422$26.61MInsider
Terry P. Gould4.56%3,402,422$26.61MInsider
Vanguard Group Inc4.39%3,280,709$25.66MInstitution
Adams Street Partners LLC4.39%3,275,616$25.62MInstitution

1 of 3

CRVS vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CRVS55.95%41.58%Net Buying
RGNX77.06%22.94%Net SellingNet Selling
PRTA49.39%50.61%Net Selling
OLMA73.04%26.96%Net BuyingNet Selling
CMPX72.63%27.37%Net Selling
View Top Biotech Stocks

Corvus Pharmaceuticals Stock Ownership FAQ

Who owns Corvus Pharmaceuticals?

Corvus Pharmaceuticals (NASDAQ: CRVS) is owned by 55.95% institutional shareholders, 41.58% Corvus Pharmaceuticals insiders, and 2.48% retail investors. Orbimed Advisors LLC is the largest individual Corvus Pharmaceuticals shareholder, owning 7.17M shares representing 9.59% of the company. Orbimed Advisors LLC's Corvus Pharmaceuticals shares are currently valued at $54.45M.

If you're new to stock investing, here's how to buy Corvus Pharmaceuticals stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.